Adult ADHD and comorbid depressive disorders: diagnostic challenges and treatment options.

Research output: Contribution to journalArticle

Abstract

Attention-deficit/hyperactivity disorder (ADHD) and major depressive disorder (MDD) are separately common mental health conditions that can have an adverse effect on a patient's quality of life if left untreated. These disorders frequently co-occur with one another, which can lead to increased patient suffering and diagnostic challenges for the treating clinician. In the United States adult population, epidemiological data show that the prevalence rate for MDD is 6.7%, while the ADHD prevalence rate in US adults is 4.4%. This epidemiological data represents the general population and likely underestimates the prevalence rates in clinic or practice patients. Examining the concurrent comorbid rate, if a patient has MDD, the likelihood of that patient also having ADHD is 18.6%; if the patient has ADHD, the likelihood of that patient having comorbid MDD is 9.4%. If the patient has dysthymia, the comorbid rate of ADHD is 12.8%, while those adults with ADHD have a comorbid rate of dysthymia of 22.6%.

Original languageEnglish (US)
Pages (from-to)5-7
Number of pages3
JournalCNS Spectrums
Volume14
Issue number7 Suppl 6
StatePublished - Jul 2009

Fingerprint

Attention Deficit Disorder with Hyperactivity
Depressive Disorder
Major Depressive Disorder
Therapeutics
Psychological Stress
Population
Mental Health
Quality of Life

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Adult ADHD and comorbid depressive disorders : diagnostic challenges and treatment options. / Goodman, David.

In: CNS Spectrums, Vol. 14, No. 7 Suppl 6, 07.2009, p. 5-7.

Research output: Contribution to journalArticle

@article{d4b76ba096224b06914d657d0cf86554,
title = "Adult ADHD and comorbid depressive disorders: diagnostic challenges and treatment options.",
abstract = "Attention-deficit/hyperactivity disorder (ADHD) and major depressive disorder (MDD) are separately common mental health conditions that can have an adverse effect on a patient's quality of life if left untreated. These disorders frequently co-occur with one another, which can lead to increased patient suffering and diagnostic challenges for the treating clinician. In the United States adult population, epidemiological data show that the prevalence rate for MDD is 6.7{\%}, while the ADHD prevalence rate in US adults is 4.4{\%}. This epidemiological data represents the general population and likely underestimates the prevalence rates in clinic or practice patients. Examining the concurrent comorbid rate, if a patient has MDD, the likelihood of that patient also having ADHD is 18.6{\%}; if the patient has ADHD, the likelihood of that patient having comorbid MDD is 9.4{\%}. If the patient has dysthymia, the comorbid rate of ADHD is 12.8{\%}, while those adults with ADHD have a comorbid rate of dysthymia of 22.6{\%}.",
author = "David Goodman",
year = "2009",
month = "7",
language = "English (US)",
volume = "14",
pages = "5--7",
journal = "CNS Spectrums",
issn = "1092-8529",
publisher = "MBL Communications",
number = "7 Suppl 6",

}

TY - JOUR

T1 - Adult ADHD and comorbid depressive disorders

T2 - diagnostic challenges and treatment options.

AU - Goodman, David

PY - 2009/7

Y1 - 2009/7

N2 - Attention-deficit/hyperactivity disorder (ADHD) and major depressive disorder (MDD) are separately common mental health conditions that can have an adverse effect on a patient's quality of life if left untreated. These disorders frequently co-occur with one another, which can lead to increased patient suffering and diagnostic challenges for the treating clinician. In the United States adult population, epidemiological data show that the prevalence rate for MDD is 6.7%, while the ADHD prevalence rate in US adults is 4.4%. This epidemiological data represents the general population and likely underestimates the prevalence rates in clinic or practice patients. Examining the concurrent comorbid rate, if a patient has MDD, the likelihood of that patient also having ADHD is 18.6%; if the patient has ADHD, the likelihood of that patient having comorbid MDD is 9.4%. If the patient has dysthymia, the comorbid rate of ADHD is 12.8%, while those adults with ADHD have a comorbid rate of dysthymia of 22.6%.

AB - Attention-deficit/hyperactivity disorder (ADHD) and major depressive disorder (MDD) are separately common mental health conditions that can have an adverse effect on a patient's quality of life if left untreated. These disorders frequently co-occur with one another, which can lead to increased patient suffering and diagnostic challenges for the treating clinician. In the United States adult population, epidemiological data show that the prevalence rate for MDD is 6.7%, while the ADHD prevalence rate in US adults is 4.4%. This epidemiological data represents the general population and likely underestimates the prevalence rates in clinic or practice patients. Examining the concurrent comorbid rate, if a patient has MDD, the likelihood of that patient also having ADHD is 18.6%; if the patient has ADHD, the likelihood of that patient having comorbid MDD is 9.4%. If the patient has dysthymia, the comorbid rate of ADHD is 12.8%, while those adults with ADHD have a comorbid rate of dysthymia of 22.6%.

UR - http://www.scopus.com/inward/record.url?scp=70350452017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350452017&partnerID=8YFLogxK

M3 - Article

C2 - 19773716

AN - SCOPUS:70350452017

VL - 14

SP - 5

EP - 7

JO - CNS Spectrums

JF - CNS Spectrums

SN - 1092-8529

IS - 7 Suppl 6

ER -